Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats

Epilepsia

Volumn 38, Issue 11, 1997, Pages 1167-1172

  Wlaź, Piotr ^a   Löscher, Wolfgang ^b  

^a UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Amygdala; Felbamate; Kindling

Indexed keywords

FELBAMATE;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPORAL LOBE EPILEPSY;

AMYGDALA; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; KINDLING, NEUROLOGIC; PHENYLCARBAMATES; PROPYLENE GLYCOLS; RATS; RATS, WISTAR;

EID: 1842364874     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb01212.x     Document Type: Article

References (29)

1. White HS, Wolf HH, Swinyard EA, Skeen GA, Sofia RD. A neuropharmacological evaluation of felbamate as a novel anticonvulsant. Epilepsia 1992;33:564-72.
2. Yamaguchi S, Rogawski MA. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res 1992;11: 9-16.
3. Chronopoulos A, Stafstrom C, Thurber S, Hyde P, Mikati M, Holmes GL. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. Epilepsia 1993;34:359-66.
4. Sofia RD, Gordon R, Gels M, Diamantis W. Effects of felbamate and other anticonvulsant drugs in two models of status epilepticus in the rat. Res Commun Chem Pathol Pharmacol 1993;79:335-41.
5. Wasterlain CG, Adams LM, Schwartz PH, Hattori H, Sofia RD, Wichmann JK. Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia. Neurology 1993;43: 2303-10.
6. Wasterlain CG, Adams LM, Wichmann JK, Sofia RD. Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia. Stroke 1996;27:1236-40.
7. Ritter FJ, Leppik IE, Dreifuss FE, et al. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
8. Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 1992;32:386-92.
9. Faught E, Sachdeo RC, Remler MP, et al. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 1993; 43:688-92.
10. Juul-Jensen P. Epidemiology of intractable epilepsy. In: Schmidt D, Morselli P, eds. Intractable epilepsy: experimental and clinical aspects. New York: Raven Press, 1986:5-11.
11. Löscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 1988;2:145-81.
12. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press, 1986.
13. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972;32:281-94.
14. Ebert U, Rundfeldt C, Löscher W. Development and pharmacological suppression of secondary afterdischarges in the hippocampus of amygdala-kindled rats. Eur J Neurosci 1995;7:732-41.
15. Freeman FG, Jarvis MF. The effect of interstimulation interval on the assessment and stability of kindled seizure thresholds. Brain Res Bull 1981;7:629-33.
16. Rundfeldt C, Hönack D, Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology 1990;29:845-51.
17. Löscher W, Hönack D. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther 1991;256:432-40.
18. Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in mice and rats. J Am Pharm Assoc 1957;46: 208-9.
19. Theodore WH, Jensen PK, Kwan RMF. Felbamate: clinical use. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven Press, 1995:817-22.
20. McCabe RT, Wasterlain CG, Kucharczyk N, Sofia RD, Vogel JR. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J Pharmacol Exp Ther 1993;264:1248-52.
21. Coffin V, Cohen-Williams M, Barnett A. Selective antagonism of the anticonvulsant effects of felbamate by glycine. Eur J Pharmacol 1994;256:R9-10.
22. 2+ concentration. Eur J Pharmacol 1995; 289:229-33.
23. Lösher W, Wlaź P, Rundfeldt C. Baran H, Hönack D. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Br J Pharmacol 1994;112:97-106.
24. Swinyard EA, Sofia RD, Kupferberg HJ. Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats. Epilepsia 1986;27:27-34.
25. Carter AJ. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J Pharmacol Exp Ther 1994;269:573-80.
26. Albertson TE, Peterson SL, Stark LG. Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats. Neuropharmacology 1980;19:643-52.
27. Mace JA, Burnham WM. The effect of repeated seizures on anticonvulsant drug response in the kindling model. Elecrtroencephalogr Clin Neurophysiol 1987;67:171-5.
28. Racine R, Livingston K, Joaquin A. Effects of procaine hydrochloride, diazepam, and diphenylhydantoin on seizure development in cortical and subcortical structures in rats. Electroencephalogr Clin Neurophysiol 1975;38:355-65.
29. Leppik IE. Felbamate. Epilepsia 1995;36(suppl 2):S66-72.